2020年國際 SCI 論文
| 編號 | 篇名 | 作者 | 期刊 | 卷期 |
| 1 | Independent Risk Factors for Death in Patients Admitted for Asthma Exacerbation in Taiwan | Chang YL, Ko HK, Lu MS, Chou CL, Su KC, Hsu CC, Chou KT, Chen TJ, Perng DW, Chou YC |
NPJ Prim Care Respir Med |
2020;30:7 |
| 2 | Low dose of propranolol treatment is associated with better survival in cirrhotic patients with hepatic encephalopathy | Lee PC, Chen YJ, Chou YC, Lee KC, Chen PH, Kao WY, Huang YH, Huo TI, Lin HC, Hou MC, Lee FY, Wu JC, Su CW | Eur J Gastroenterol Hepatol | 2020;32:365-372 |
| 3 | Role of the Mitochondrial Stress Response in Human Cancer Progression | Wang SF, Chen S, Tseng LM, Lee HC | Exp Biol Med | 2020;245:861-78 |
| 4 | Potential Therapeutic Agents Against COVID-19: What We Know So Far | Lu CC, Chen MY, Lee WS, Chang YL | J Chin Med Assoc | 2020;83:534-6 |
| 5 | ROS Mediate xCT-Dependent Cell Death in Human Breast Cancer Cells Under Glucose Deprivation | Chen MC, Hsu LL, Wang SF, Hsu CY, Lee SH, Tseng LM | Cells | 2020;9:E1598 |
| 6 | Judicious Use of Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Diabetes on Coronavirus-19 Pandemic | Chen CF, Chen YT, Chen TH, Chen FY, Yang YP, Wang ML, Huo TI, Chang YL, Tan AC, Lin CC | J Chin Med Assoc | 2020;83:809-811. |
| 7 | The Pharmacological Development of Direct Acting Agents for Emerging Needed Therapy Against SARS-CoV-2 | Wang SF, Chen KH, Wang SY, Yarmishyn AA, Lai WY, Lin YY, Wang ML, Chou SJ, Yang YP, Chang YL | J Chin Med Assoc | 2020;83:712-718. |
| 8 | Pharmacological Development of the Potential Adjuvant Therapeutic Agents Against Coronavirus Disease 2019 | Chen KH, Wang SF, Wang SY, Yang YP, Wang ML, Chiou SH, Chang YL | J Chin Med Assoc | 2020;83:817-821. |
| 9 | The Efficacy of First-Line Tyrosine Kinase Inhibitors Combined with Co-medications in Asian Patients with EGFR Mutation Non-Small Cell Lung Cancer | Su VYF, Yang KY, Huang TY, Hsu CC, Chen YM, Yen JC, Chou YC, Chang YL, He CH | Sci Rep | 2020;10:14965 |
| 10 | Precipitating factors causing hyperbilirubinemia during chronic hepatitis C treatment with paritaprevir/ritonavir, ombitasvir, and dasabuvir | Wang YK, Lee WP, Wang YW, Huang YH, Hou MC, Chang YL, Lan KH | J Chin Med Assoc | 2020;10.1097 |
| 11 | Changes in the Systemic Expression of Sirtuin-1 and Oxidative Stress after Intravitreal Anti-Vascular Endothelial Growth Factor in Patients with Retinal Vein Occlusion | Hwang DK, Chang YL, Lin TC, Peng CH, Chien KH, Tsai CY, Chen SJ, Chen KH, Hsu MY | Biomolecules | 2020;10:E1414 |
| 12 | Hematologic Adverse Drug Reactions Leading to Hospitalization among Cancer Patients: A Retrospective Case-Control Study | Chiou BL, Ho CC, Yang CC | J Chin Med Assoc | 2020; 83: 784-790 |
| 13 | DNAJA3/Tid1 Is Required for Mitochondrial DNA Maintenance and Regulates Migration and Invasion of Human Gastric Cancer Cells | Wang SF, Huang KH, Tseng WC, Lo JF, Li AFY, Fang WL, Chen CF, Yeh TS, Chang YL, Chou YC, Hung HH, Lee HC. | Cancers | 2020;12:3463 |
| 14 | Epidemiologic Analysis of Taiwanese Patients with Idiopathic Pulmonary Fibrosis | Yang SN, Perng DW, Ko HK, Chang YL, Hsu CC, Huang HY, Chung MI |
HEALTHCARE |
2020;8:580 |
| 15 | Efficacy and Safety of Rituximab in Autoimmune and Microangiopathic Hemolytic Anemia: A Systematic Review and Meta-Analysis | Chao SH, Chang YL, Yen JC, Liao HT, Wu TH, Yu CL, Tasi CY, Chou YC | Exp Hematol Oncol | 2020;9:6 |
2020年非 SCI 論文
|
編號 |
篇名 |
作者 |
期刊 |
卷期 |
|---|---|---|---|---|
| 1 | 改善心跳停止急救復甦後病人之低溫治療給藥流程 | 翁如潔、張惠娟、林美玲、王斯郁 | 醫院藥學 | 2020; 37:1-9 |
| 2 | 人類免疫缺乏病毒治療進展之案例用藥探討 | 黃聿璿、何沁沁 | 醫院藥學 | 2020; 37:10-17 |
| 3 | 纖維肌痛症之治療 | 黃冠慈、王斯郁 | 醫院藥學 | 2020; 37:18-24 |
| 4 | 不孕症之藥物治療 | 胡晉嘉、蔡涵怡 | 醫院藥學 | 2020; 37:25-33 |
| 5 | 缺血性腦中風治療 | 陳佳慧、周千瀅 | 醫院藥學 | 2020; 37:34-39 |
| 6 | 心房顫動之藥物治療 | 陳柏瑋、王斯郁 | 醫院藥學 | 2020; 37:40-52 |
| 7 | 庫欣氏症之藥物治療 | 林聖凰、許家禎 | 醫院藥學 | 2020; 37:53-58 |
| 8 | 簡介老人潛在不適當用藥 | 王明業、周千瀅 | 醫院藥學 | 2020; 37:59-64 |
| 9 | 類風濕性關節炎之治療現況 | 李簥安、朱佩欣 | 醫院藥學 | 2020; 37:65-71 |
| 10 | 淺談良性攝護腺增生之中西醫藥物治療 | 林益生、周千瀅 | 醫院藥學 | 2020; 37:72-78 |
| 11 | 亨丁頓氏舞蹈症治療新藥Deutetrabenazine | 黃冠慈、何沁沁 | 醫院藥學 | 2020; 37:79-85 |
| 12 | 疑似Timolol眼藥水引起心搏過緩 | 陳佳慧、陳奇良、李婉詩 | 醫院藥學 | 2020; 37:94-99 |
| 13 | 吸入途徑給予Tranexamic acid治療咳血 | 陳美瑜、蔡涵怡 | 醫院藥學 | 2020; 37:100-104 |
| 14 | 疑似重複投予piperacillin/tazobactam引起白血球及血小板快速降低 | 林于瑄、何沁沁 | 醫院藥學 | 2020; 37:105-112 |
| 15 | 氣喘之治療新趨勢 | 盧孟穗、蔡涵怡 | 醫院藥學 | 2020; 37:113-119 |
| 16 | 急性腎盂腎炎之治療 | 盧志嘉、蔡涵怡 | 醫院藥學 | 2020; 37:120-124 |
| 17 | 分化型甲狀腺癌之治療 | 林聖凰、何沁沁 | 醫院藥學 | 2020; 37:125-128 |
| 18 | 新生兒尿素循環障礙疾病之治療 | 余聲隆、許家禎 | 醫院藥學 | 2020; 37:137-141 |
| 19 | 轉移性黑色素瘤之藥品治療新趨勢 | 施立于、陳奇良、何沁沁 | 醫院藥學 | 2020; 37:142-151 |
| 20 | 潛伏性結核用藥與抗反轉錄病毒藥物之藥物交互作用探討 | 黃聿璿、朱佩欣 | 醫院藥學 | 2020; 37:152-160 |
最後更新：